---
canonical_url: https://www.stockexpertai.com/earnings/epam
last_updated: 2026-05-09T17:02:42.290Z
---

# EPAM Systems, Inc. (EPAM) Q1 FY2027 Earnings Preview

> This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-09T17:02:41.851Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $99.23 (▼ -4.81%) | fmp:quote |
| Market Cap | $5.2B | fmp:profile |
| 52w range | $98.76 – $222.53 | fmp:quote |
| Earnings | Thu 6 Aug | fmp:earnings-history |
| EPS estimate | $3.12 (+13% YoY) | fmp:earnings-estimate |
| Revenue estimate | $1.4B | fmp:earnings-estimate |
| Beat streak | 8/4 | fmp:earnings-history |
| Rating | A (overall 4/5) | fmp:ratings |
| Analyst median target | $140 (+40.6% upside) | fmp:price-target-consensus |
| MoonshotScore | 33/100 | derived |
| Council | 5/6 bullish | derived |
| Munger verdict | Undervalued | derived |

## EPAM Systems, Inc. — Q1 FY2027 Expectations

Q1 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$1.4B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$3.12</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 8 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** A · **Stance:** BUY · **Council:** 5/6 · **Moonshot:** 33

= MoonshotScore <strong>33</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9-pillar formula">[9-pillar formula]</sup> + Council <strong>5/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (4 metrics)

### 1. Fy26 Revenue Guidance Revised

EPAM is lowering its full year revenue growth outlook to a range of 4% to 6.5% due to higher energy prices and global economic uncertainty.

> "At the same time, we are now expecting that higher energy prices and global economic uncertainty will have an impact on our revenue growth rate for the year. As a result, we are lowering our full year revenue growth outlook. Revenue growth will now be in the range of 4% to 6.5%."
> — Jason Peterson, Chief Financial Officer, Expectation / Guide · Q1 FY2026

### 2. Q2 Revenue Guidance

EPAM expects revenue for Q2 2026 to be in the range of $1.4 billion to $1.415 billion, producing year-over-year growth of 4% at the midpoint of the range.

> "We expect revenue to be in the range of $1.4 billion to $1.415 billion, producing year-over-year growth of 4% at the midpoint of the range."
> — Jason Peterson, Chief Financial Officer, Expectation / Guide · Q1 FY2026

### 3. Ai Native Revenue Growth

EPAM's AI native revenues exceeded $125 million in Q1, marking the fifth consecutive quarter of double-digit sequential growth.

> "AI native and AI foundational revenues continued to contribute to year-over-year growth with more than $125 million AI native revenues in the quarter. This is the fifth consecutive quarter of sequential double-digit growth."
> — Jason Peterson, Chief Financial Officer, Investor Focus · Q1 FY2026

### 4. Share Repurchases

EPAM repurchased approximately 1.8 million shares in Q1 for $264 million at an average price of $143.84 per share, returning approximately $1.5 billion in cash to shareholders to date.

> "Share repurchases in the first quarter were approximately 1.8 million shares for [ $264 million ] at an average price of $143.84 per share. To date, since the initiation of our share repurchase program, we've returned approximately $1.5 billion in cash to shareholders."
> — Jason Peterson, Chief Financial Officer, Investor Focus · Q1 FY2026


## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 2.0 | weak | Q1 vs Q2: moderate growth (+3.4%) |
| Gross Margin | 3.0 | weak | Q1: low margin (25.6%, capital-intensive or commodity) |
| Operating Leverage | 1.0 | weak | op margin average (8.5%) |
| Cash Runway | 3.0 | weak | FCF negative ($-0.1B, external financing needed) |
| R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) |
| Price Momentum | 4.0 | medium | RSI 17.6 oversold, 50d below |
| News Sentiment | 7.0 | strong | majority buy (65%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +40.6% |
| Ken Griffin | bear | flow · 50d MA below |
| Jim Simons | bull | quant · RSI 18 |
| Klarman | bull | value · target upside +40.6% |
| Buffett | bull | quality · ROE score 4/5 |
| Munger | bull | valuation · target upside +40.6% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Undervalued
- **Financial Health:** Strong
- **Margin of Safety:** Strong
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 17.6 — oversold (RSI 17.6) — tepki alımı potansiyeli
- **50d MA:** $129 — hisse %23.4 altında — kısa vadeli direnç
- **200d MA:** $164 — hisse %39.6 altında — uzun vadeli baskı
- **Volume (10d):** +38%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q2 FY25 | $2.77 | $2.61 | BEAT | +0.2% |
| Q3 FY25 | $3.08 | $3.03 | BEAT | +4.3% |
| Q4 FY25 | $3.26 | $3.16 | BEAT | -0.2% |
| Q1 FY26 | $2.86 | $2.75 | +4.0% EPS | -4.8% |

Q1 (May 7, 2026): EPS $2.86 vs $2.75 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +4.0% beat. D+1 movement: -4.8%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q1 EPS > $3.12 + CapEx discipline**

Threshold: EPS > $3.12<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $140<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $247<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $3.12 + CapEx < $17.9M**

Threshold: EPS ≈ $3.12<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q1 CapEx < $17.9M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $99<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $140<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $3.03 or CapEx ≥ $17.9M**

Threshold: EPS < $3.03<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $99 below SMA200 $164<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $140<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q1: EPS $2.86 vs $2.75 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock -4.8% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26

### CapEx shock
Q1 CapEx $17.9M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q1 op margin 8.5%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q1 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $140 (+40.6% upside vs current $99)
- **High / Low:** $247 / $110
- **Buy / Hold / Sell:** 13 / 7 / 0
- **Analyst count:** 9 (last quarter), 51 all-time

## Additional Transcript Insights

### 1. ai_native_revenue_growth

**Claim:** EPAM's AI native revenues exceeded $125 million in Q1, marking the fifth consecutive quarter of double-digit sequential growth.

**Evidence (transcript):** "AI native and AI foundational revenues continued to contribute to year-over-year growth with more than $125 million AI native revenues in the quarter. This is the fifth consecutive quarter of sequential double-digit growth."

**Numbers:** $125 million

### 2. fy26_revenue_guidance_revised

**Claim:** EPAM is lowering its full year revenue growth outlook to a range of 4% to 6.5% due to higher energy prices and global economic uncertainty.

**Evidence (transcript):** "At the same time, we are now expecting that higher energy prices and global economic uncertainty will have an impact on our revenue growth rate for the year. As a result, we are lowering our full year revenue growth outlook. Revenue growth will now be in the range of 4% to 6.5%."

**Numbers:** 4%, 6.5%

### 3. north_america_underperformance

**Claim:** EPAM notes that underperformance in North America is contributing to lower visibility in the second half.

**Evidence (transcript):** "We are particularly seeing underperformance in North America, and this is contributing to lower visibility in the second half."

**Numbers:** —

### 4. ai_deal_pipeline

**Claim:** EPAM is seeing an accelerating large-deal pipeline focused on AI-enabled vendor consolidations, which are larger than their historical norm and expected to scale over time.

**Evidence (transcript):** "EPAM is seeing an oxalating large-deal pipeline focused on AI-enabled vendor consolidations, where EPAM has significant opportunity to gain market share. These multiyear deals are larger than our historical norm are expected to scale over time and include a range of commercial models."

**Numbers:** —

### 5. q2_revenue_guidance

**Claim:** EPAM expects revenue for Q2 2026 to be in the range of $1.4 billion to $1.415 billion, producing year-over-year growth of 4% at the midpoint of the range.

**Evidence (transcript):** "We expect revenue to be in the range of $1.4 billion to $1.415 billion, producing year-over-year growth of 4% at the midpoint of the range."

**Numbers:** $1.4 billion, $1.415 billion, 4%

### 6. share_repurchases

**Claim:** EPAM repurchased approximately 1.8 million shares in Q1 for $264 million at an average price of $143.84 per share, returning approximately $1.5 billion in cash to shareholders to date.

**Evidence (transcript):** "Share repurchases in the first quarter were approximately 1.8 million shares for [ $264 million ] at an average price of $143.84 per share. To date, since the initiation of our share repurchase program, we've returned approximately $1.5 billion in cash to shareholders."

**Numbers:** 1.8 million, $264 million, $143.84, $1.5 billion


---

*Data source: FMP (live query, 2026-05-09), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*
